Non-tuberculous mycobacteria (NTM) are a group of bacteria that are capable of causing opportunistic lung infections and the development of NTM pulmonary disease (NTM-PD).

In this article we review the major changes in the 2023 GOLD report as they impact on the initial and ongoing pharmacological management of COPD and consider the implications for primary care in the UK.

This pragmatic guide on the identification, referral and ongoing management of adults and children with severe asthma has been developed by an expert group led by Dr Steve Holmes, a GP based in Shepton Mallet, Somerset and including Will Carroll, University Hospital of the North Midlands, Stoke-o

The publication of the 2023 GOLD Report Global Strategy for Prevention, Diagnosis and Management of COPD represents a shift in the global recommendations for how we should view, categorize and ultimately treat chron

PCRS welcome the verdict of the inquest into the death of 2-year-old Awaab Ishak in Rochdale in 2020.

Virtual consultations, virtual wards and virtual pulmonary rehab have enabled continued safe patient – practitioner interaction during the COVID-19 pandemic and looks set to remain in place due to clear benefits in terms of protecting vulnerable patients from unnecessary infection or travel, keep

Many of us have embraced digital learning over the past two years – attending online conferences, workshops and events. There is no doubt that digital learning is here to stay. But how do we maintain quality, how do we keep people engaged.

To mark World COPD Day we have recorded a special podcast exploring the topic of Exacerbations in COPD. Featuring Dr.

World COPD Day, 16th November, is organised by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) in collaboration with health care professionals and COPD patient groups throughout the world.

Reducing the environmental impact of single use inhalers for the treatment of asthma and other respiratory diseases has become an important touch point as the NHS seeks to achieve its promised

Digital health has come to the fore with the COVID pandemic. Some apps and digital strategies are welcome and we wish we had adopted them years ago – other initiatives are not so effective and we have concerns about how they will affect the healthcare we provide.

Vikki Knowles - Surrey: Minimising MDIs Independent Respiratory Nurse Specialist Vikki Knowles shares the early stages of work being done to minimise the use of Metered Dose Inhalers (MDIs) in their practice in Surrey and how that can positively impact the greener healthcare environment

Dr Kat Parker - Bristol: Switching to DPIs In this case study from Dr Kat Parker, she shares her experience of how her practice in Bristol has been switching patients from Metered Dose Inhalers (MDIs) to Dry Powder Inhalers (DPIs) where appropriate to do so, when and how they communicat

Part of our Digital Technology Webinar Series 2022, exploring the ethics and inequalities of digital technology